Roberto Salgado
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- CAR-T cell therapy research
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
Papers in
- Oncology 18
- Cancer Immunotherapy and Biomarkers 11
- HER2/EGFR in Cancer Research 5
-
- Cancer Genomics and Diagnostics 11
- Breast Cancer Treatment Studies 8
- Co-authors
- Christos Sotiriou (11 shared papers)Sherene Loi (7 shared papers)Francisco J. Esteva (1 shared paper)Sanne Lysbet de Haas (1 shared paper)Mark Beresford (1 shared paper)Seock‐Ah Im (1 shared paper)Jigna Shah (1 shared paper)Leisha A. Emens (1 shared paper)
- Journals
- Cancer Research (7 papers)Journal of Clinical Oncology (5 papers)Clinical Chemistry and Laboratory Medicine (CCLM) (2 papers)European Journal of Cancer (2 papers)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- BelgiumUnited StatesAustralia
In The Last Decade
Roberto Salgado
30 papers receiving 815 citations
Roberto Salgado's Hit Papers
Peers
Comparison fields: 5 of 71
- Oncology 555
- Cancer Research 246
- Radiology, Nuclear Medicine and Imaging 204
- Health Informatics 11
- Immunology 133
Countries citing papers authored by Roberto Salgado
This map shows the geographic impact of Roberto Salgado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Salgado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Salgado more than expected).
Fields of papers citing papers by Roberto Salgado
This network shows the impact of papers produced by Roberto Salgado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Salgado. The network helps show where Roberto Salgado may publish in the future.
Co-authors
The 25 scholars most cited alongside Roberto Salgado, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Trastuzumab emtansine plus atezolizumab versus trastuzumab emtansine plus placebo in previously treated, HER2-positive advanced breast cancer (KATE2): a phase 2, multicentre, randomised, double-blind trial Hit paper breakdown → | 2020 | 280 |
| 2 | 2017 | 110 | |
| 3 | 2023 | 78 | |
| 4 | 2006 | 59 | |
| 5 | 2014 | 42 | |
| 6 | 2022 | 37 | |
| 7 | 2022 | 31 | |
| 8 | 2015 | 30 | |
| 9 | Tumor infiltrating lymphocytes (TILs) indicate trastuzumab benefit in early-stage HER2-positive breast cancer (HER2+ BC) | 2013 | 29 |
| 10 | 2013 | 17 | |
| 11 | 2018 | 15 | |
| 12 | 2023 | 15 | |
| 13 | 2014 | 11 | |
| 14 | 2017 | 10 | |
| 15 | 2019 | 8 | |
| 16 | 2023 | 7 | |
| 17 | 2005 | 7 | |
| 18 | 1984 | 7 | |
| 19 | 2022 | 6 | |
| 20 | 2022 | 6 |
About Roberto Salgado
Roberto Salgado is a scholar working on Oncology, Cancer Research, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 37 papers that have together received 822 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (11 papers), Cancer Genomics and Diagnostics (11 papers), Breast Cancer Treatment Studies (8 papers), HER2/EGFR in Cancer Research (5 papers), Radiomics and Machine Learning in Medical Imaging (5 papers), Molecular Biology Techniques and Applications (4 papers), Ferroptosis and cancer prognosis (3 papers) and AI in cancer detection (3 papers). The work is most often cited by research in Oncology (555 citations), Cancer Research (246 citations), Radiology, Nuclear Medicine and Imaging (204 citations), Health Informatics (11 citations) and Immunology (133 citations). Roberto Salgado has collaborated with scholars based in Belgium, United States and Australia. Frequent co-authors include Christos Sotiriou, Sherene Loi, Francisco J. Esteva, Sanne Lysbet de Haas, Mark Beresford, Seock‐Ah Im, Jigna Shah, Leisha A. Emens, Michelino De Laurentiis and Chiara Lambertini. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Clinical Chemistry and Laboratory Medicine (CCLM), European Journal of Cancer and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.